Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
U.S. NeuroSurgical Holdings, Inc. (USNU)
|
Add to portfolio |
|
|
|
| Price: |
$0.24
| | Metrics |
| OS: |
7.89
|
M
| |
|
|
| Market cap: |
$1.89
|
M
| |
|
|
|
Net cash:
|
$776
|
k
| |
$0.10
|
per share
|
|
EV:
|
$1.12
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 1.1 | 3.2 | 3.1 | 3.4 | 3.4 | 3.5 | 3.0 | 2.6 |
| Revenue growth | -66.6% | 3.4% | -10.3% | 0.3% | -1.2% | 16.4% | 14.0% | 6417.5% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 |
| Gross profit | 1.1 | 3.2 | 3.1 | 3.4 | 3.4 | 3.2 | 3.0 | 2.6 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 92.9% | 100.0% | 100.0% |
| Selling, general and administrative | 1.1 | 1.2 | 1.2 | 1.3 | 1.3 | 1.3 | 1.2 | 1.2 |
| EBIT | -0.6 | 0.8 | 0.1 | -0.6 | 0.6 | 1.0 | 0.8 | 0.8 |
| EBIT margin | -52.6% | 25.4% | 3.4% | -17.9% | 17.2% | 29.9% | 27.9% | 28.8% |
| Pre-tax income | -0.6 | 0.9 | 0.2 | -0.6 | 0.4 | 0.9 | 0.6 | 0.8 |
| Income taxes | 0.4 | 0.3 | 0.0 | -0.2 | -0.1 | 0.3 | 0.3 | 0.2 |
| Tax rate | | 37.7% | 6.0% | 31.3% | | 39.0% | 38.9% | 30.1% |
| Net income | -0.9 | 0.5 | 0.1 | -0.4 | 0.5 | 0.5 | 0.4 | 0.6 |
| Net margin | -83.0% | 16.8% | 4.6% | -12.3% | 15.8% | 15.5% | 13.3% | 21.5% |
| |
| Diluted EPS | ($0.11) | $0.07 | $0.02 | ($0.05) | $0.07 | $0.07 | $0.05 | $0.07 |
| Shares outstanding (diluted) | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|